Literature DB >> 27025991

Episodic ataxia type 2 manifests as epileptiform electroencephalographic activity with no epileptic attacks in two family members.

Misako Kaido1, Mitsuru Furuta, Masayuki Nakamori, Yoshihito Yuasa, Masanori P Takahashi.   

Abstract

Here, we report two cases of episodic ataxia type 2 (EA2) in a 63-year-old woman and her 36-year-old daughter. The mother experienced recurrent attacks of cerebellar dysfunction lasting 4 to 5 hours since the age of 41 years. On several occasions, she was admitted to the emergency room, where she was diagnosed with epilepsy or stroke. Based on these diagnoses, she was treated with antiepileptic or anticoagulant drugs, but both treatments were eventually discontinued. The frequency of the attacks increased after the patient reached the age of 62. Interictal neurological examination demonstrated signs of slight cerebellar ataxia, i.e. saccadic eye movements, gaze-directed nystagmus, and mild truncal ataxia. Brain magnetic resonance imaging (MRI) showed cerebellar vermis atrophy. Electroencephalography (EEG) revealed various spike and wave patterns: solitary spikes, spike-and-slow wave complexes, and slow wave bursts. Photoparoxysmal response (PPR) type 3 was also observed. Treatment with acetazolamide abolished the patient's attacks almost completely. The daughter started experiencing 5- to 10-minute ataxic episodes at the age of 16 years. Based on her epileptiform EEG activities with PPR (type 2), antiepileptic drugs (valproate and zonisamide) were prescribed. Despite pharmacological treatment, the attacks recurred; however, their frequency gradually decreased with time, until they almost entirely disappeared when the patient was 33. Unfortunately, migraine-like headaches arose instead. Subtle truncal ataxia was observed during interictal periods. Sanger sequencing of the exons of the CACNA1A gene revealed a novel single base deletion (c.3575delA) in both patients. Despite the difference in age of onset and clinical course, both patients showed clearly epileptiform EEG activities without experiencing the concurrent epileptic episodes. Thus, EA2 is a disease that may be misdiagnosed as epilepsy or stroke in the field of emergency medicine.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27025991     DOI: 10.5692/clinicalneurol.cn-000854

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  5 in total

1.  Efficacy of levetiracetam in patients with episodic ataxia type 2 caused by CACNA1A mutation: three case reports.

Authors:  Seunghee Na; Taewon Kim
Journal:  Neurol Sci       Date:  2021-06-03       Impact factor: 3.307

Review 2.  The electrophysiological footprint of CACNA1A disorders.

Authors:  Elisabetta Indelicato; Iris Unterberger; Wolfgang Nachbauer; Andreas Eigentler; Matthias Amprosi; Fiona Zeiner; Edda Haberlandt; Manuela Kaml; Elke Gizewski; Sylvia Boesch
Journal:  J Neurol       Date:  2021-02-05       Impact factor: 4.849

3.  Identification of a novel CACNA1A mutation in a Chinese family with autosomal recessive progressive myoclonic epilepsy.

Authors:  Yudan Lv; Zan Wang; Chang Liu; Li Cui
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-19       Impact factor: 2.570

4.  Genetic and phenotypic spectrum of Chinese patients with epilepsy and photosensitivity.

Authors:  Yue Niu; Pan Gong; Xianru Jiao; Zhao Xu; Yuehua Zhang; Zhixian Yang
Journal:  Front Neurol       Date:  2022-08-02       Impact factor: 4.086

Review 5.  Acetazolamide: Old drug, new evidence?

Authors:  Arif Ali Shukralla; Emma Dolan; Norman Delanty
Journal:  Epilepsia Open       Date:  2022-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.